Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FADS1 | O60427 | 6/20 | 0.78 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.63 |
| ▸ | NPC1 | O15118 | 3/20 | 0.62 |
| ▸ | RAB9A | P51151 | 3/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.62 |
| ▸ | GRM4 | Q14833 | 2/20 | 0.62 |
| ▸ | P2RX1 | P51575 | 1/20 | 0.61 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.61 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.61 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.57 |
| ▸ | MEN1 | O00255 | 3/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.57 |
| ▸ | LMNA | P02545 | 2/20 | 0.57 |
| ▸ | MAPT | P10636 | 2/20 | 0.57 |
| ▸ | HTT | P42858 | 2/20 | 0.57 |
| ▸ | GRM5 | P41594 | 2/20 | 0.57 |
| ▸ | GAA | P10253 | 1/20 | 0.56 |
| ▸ | MAOB | P27338 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29406000 | 1.00 | FADS1 (0.78) | FADS1PTGS1NPC1RAB9AALDH1A1 | |
| SCHEMBL17744881 | 0.89 | FADS1 (0.72) | FADS1PTGS1NPC1RAB9AALDH1A1 | |
| SCHEMBL9810110 | 0.84 | ALDH1A1 (0.72) | FADS1PTGS1NPC1RAB9AALDH1A1 | |
| SCHEMBL15778718 | 0.84 | FADS1 (0.74) | FADS1NPC1RAB9AALDH1A1GRM4 | |
| SCHEMBL4738811 | 0.84 | FADS1 (0.72) | FADS1NPC1RAB9AALDH1A1KDM4E | |
| SCHEMBL2701738 | 0.83 | FADS1 (1.00) | FADS1NPC1RAB9AALDH1A1KDM4E | |
| SCHEMBL31424193 | 0.83 | MEN1 (0.72) | FADS1PTGS1NPC1RAB9AALDH1A1 | |
| SCHEMBL5668126 | 0.83 | FADS1 (0.65) | FADS1PTGS1NPC1RAB9AALDH1A1 | |
| SCHEMBL259352 | 0.83 | MEN1 (0.72) | FADS1PTGS1NPC1RAB9AALDH1A1 | |
| SCHEMBL8485797 | 0.83 | FADS1 (0.65) | FADS1PTGS1NPC1RAB9AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 135 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105814209-B | Microbial oils containing dihomo-gamma-linolenic acid and microbial biomass containing dihomo-gamma-linolenic acid | 日本水产株式会社 | 2022-02-25 | — | — | CN | claimed |
| CN-112980897-A | Preparation method of microbial oil containing dihomo-gamma-linolenic acid | 日本水产株式会社 | 2021-06-18 | — | — | CN | claimed |
| EP-3733857-A2 | DIHOMO-GAMMA-LINOLENIC ACID-CONTAINING MICROBIAL OIL AND DIHOMO-GAMMA-LINOLENIC ACID-CONTAINING MICROBIAL BIOMASS | Nippon Suisan Kaisha, Ltd. (JP) | 2020-11-04 | — | — | EP | claimed |
| EP-3563690-A2 | DIHOMO-GAMMA-LINOLENIC ACID-CONTAINING MICROBIAL OIL AND DIHOMO-GAMMA-LINOLENIC ACID-CONTAINING MICROBIAL BIOMASS | Nippon Suisan Kaisha, Ltd. (JP) | 2019-11-06 | — | — | EP | claimed |
| US-20180042230-A1 | DIHOMO-GAMMA-LINOLENIC ACID-CONTAINING MICROBIAL OIL AND DIHOMO-GAMMA-LINOLENIC ACID-CONTAINING MICROBIAL BIOMASS | NIPPON SUISAN KAISHA, LTD. (JP) | 2018-02-15 | — | — | US | claimed |
| US-20170000116-A1 | DIHOMO-GAMMA-LINOLENIC ACID-CONTAINING MICROBIAL OIL AND DIHOMO-GAMMA-LINOLENIC ACID-CONTAINING MICROBIAL BIOMASS | NIPPON SUISAN KAISHA, LTD. (JP) | 2017-01-05 | — | — | US | claimed |
| EP-3077489-A2 | DIHOMO- -LINOLENIC ACID-CONTAINING MICROBIAL OIL AND DIHOMO- -LINOLENIC ACID-CONTAINING MICROBIAL BIOMASS | Nippon Suisan Kaisha, Ltd. (JP) | 2016-10-12 | — | — | EP | claimed |
| WO-2015083843-A2 | DIHOMO-γ-LINOLENIC ACID-CONTAINING MICROBIAL OIL AND DIHOMO-γ-LINOLENIC ACID-CONTAINING MICROBIAL BIOMASS | NIPPON SUISAN KAISHA, LTD. (JP) | 2015-06-11 | — | — | WO | claimed |
| CN-104193898-A | Salt-free high-temperature-resistant powder butadiene-acrylonitrile rubber | SHENGDONG TECHNOLOGY CO LTD | 2014-12-10 | — | — | CN | claimed |
| CN-104193907-A | High-temperature resistant powdered acrylonitrile-butadiene rubber | SHENGDONG TECHNOLOGY CO LTD | 2014-12-10 | — | — | CN | claimed |
| CN-117510415-A | Synthesis method of quinazolinone compound | 中国人民解放军军事科学院防化研究院 | 2024-02-06 | — | — | CN | disclosed |
| US-11856952-B2 | Microbial oil, production method for microbial oil, concentrated microbial oil, and production method for concentrated microbial oil | NIPPON SUISAN KAISHA, LTD. (JP) | 2024-01-02 | — | — | US | disclosed |
| CN-111646908-B | Method for preparing aromatic amine compound | 宜昌尚诺德生物医药科技有限公司 | 2023-03-10 | — | — | CN | disclosed |
| CN-111732493-B | Synthesis process of arylamine compound | 宜昌尚诺德生物医药科技有限公司 | 2023-01-24 | — | — | CN | disclosed |
| US-20220248671-A1 | MICROBIAL OIL, PRODUCTION METHOD FOR MICROBIAL OIL, CONCENTRATED MICROBIAL OIL, AND PRODUCTION METHOD FOR CONCENTRATED MICROBIAL OIL | NIPPON SUISAN KAISHA, LTD. (JP) | 2022-08-11 | — | — | US | disclosed |
| US-20020019414-A1 | N-aryl(thio)anthranilic acid amide derivatives, their preparation and their use as VEGF receptor tyrosine kinase inhibitors | NOVARTIS AG (CH) | 2002-02-14 | — | — | US | disclosed |
| CN-1331680-A | N-aryl (thio) anthranilic acid amide derivatives, their prepn. and their use as VEGF receptor tyrosine kinase inhibitors | NOVARTIS AG (CH) | 2002-01-16 | — | — | CN | disclosed |
| US-6313122-B1 | AS INHIBITORS OF FACTOR XA AND ARE USED AS ANTICOAGULANTS IN MAMMALS | ELI LILLY AND COMPANY | 2001-11-06 | — | — | US | disclosed |
| EP-1014962-A1 | ANTITHROMBOTIC AGENTS | ELI LILLY AND COMPANY (US) | 2000-07-05 | — | — | EP | disclosed |
| WO-1999000121-A1 | ANTITHROMBOTIC AGENTS | ELI LILLY AND COMPANY (US) | 1999-01-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170000116-A1 | DIHOMO-GAMMA-LINOLENIC ACID-CONTAINING MICROBIAL OIL AND DIHOMO-GAMMA-LINOLENIC ACID-CONTAINING MICROBIAL BIOMASS | DAGLA, DAGLB, DGKA | FADS1 34/4885PTGS1 257/4885NPC1 2694/4885 |
| US-20020019414-A1 | N-aryl(thio)anthranilic acid amide derivatives, their preparation and their use as VEGF receptor tyrosine kinase inhibitors | AXL, TYRO3, KDR | FADS1 3125/4885PTGS1 826/4885NPC1 4229/4885 |
| US-20180042230-A1 | DIHOMO-GAMMA-LINOLENIC ACID-CONTAINING MICROBIAL OIL AND DIHOMO-GAMMA-LINOLENIC ACID-CONTAINING MICROBIAL BIOMASS | DAGLA, DAGLB, DGKA | FADS1 34/4885PTGS1 257/4885NPC1 2694/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.